Quick Answer
When a clinic’s services involve compounded ketamine or outside pharmacy relationships, the insurance review may include more detailed questions about sourcing, handling, documentation, and responsibility.
Why product exposure comes up
A professional liability policy may not address every allegation tied to medication sourcing, formulation, contamination, labeling, storage, or handling.
What to document
The review should identify who prescribes, who compounds, who dispenses, who administers, how medication is stored, and how the clinic documents consent and adverse events.
Keep claims modest
The insurance conversation should not make clinical claims. It should focus on organizing the operation clearly for a specialty review.
Specialty Review
For the main campaign page, see Emerging Therapy Provider Insurance. To start a confidential review, email Joel with your practice structure, operating states, requested limits, and renewal timing.
FAQ
Does every clinic need product liability?
Not always. It depends on the operation, contracts, medication flow, and policy details.
Should pharmacy relationships be shared?
Yes. Medication sourcing and responsibility should be clear during the review.
Can WHINS advise on FDA rules?
No. WHINS can help with insurance placement. Regulatory questions should go to qualified counsel or compliance advisors.
Written by Joel Wagner, CIC. CA License #0G69009 | NPN #14412329. WHINS Insurance Agency | CA Agency License #0G66655.
This post is general insurance information. Coverage is subject to review and the terms, conditions, limitations, and exclusions of the issued policy. It does not provide medical, legal, regulatory, or licensing advice.
